INSIGHTS
February 10, 2025

Mission: AI Possible

A new kind of secret agent—agentic AI—is infiltrating various industries. Companies like DeepSeek, OpenAI, and Google are building new models that support agentic AI–a type of AI that enables AI agents to not only automate tasks but also make autonomous decisions, continuously monitoring the degree to which the tasks they perform meet established goals. On the healthcare scene, IQVIA and NVIDIA are collaborating to bring agentic automation into clinical research workflows, while GenAI startup Vantiq announced plans to bring agentic AI into health systems for ICU capacity management, equipment availability tracking, and care team coordination. Digital MSK provider Sword Health announced plans to rebrand as an “AI-first” care delivery model, expanding its AI agent Phoenix—which autonomously leads digital physical therapy sessions—into new therapeutic areas (e.g., mental health). Health systems are eyeing these agents for their potential to improve care coordination and shoulder some direct patient interactions. Still, industry leaders must stay in control of the mission, ensuring these digital agents—rather than becoming unpredictable operatives—remain allies that activate top-of-license practice.

Headlines

Dr. Oz Set To Take Over $1.5T Health Agency
Bringing an atypical career backdrop, Dr. Oz will oversee healthcare for patients most in need STAT

The Medicaid Innovation Outlook—Where Are We And Where Do We Go From Here?
Suggestions for digital health innovators and startups seeking contracts with Medicaid MCOs Medium

Elon Musk's Department Of Government Efficiency Gains Access To CMS
Concerns mount following consequences of USAID overhaul and vanished health data Healthcare Dive

American Hospital Association Asks Trump To Exempt Devices From Import Tariffs
Hospitals voice concerns that tariffs could impede life-saving surgeries and worker protection Healthcare Dive

To Protect Against Alzheimer’s, Researchers Look To Weight Loss Drugs
Early findings suggest GLP-1 use may reduce risk of dementia, and new studies underway The New York Times

Recent Funding